Grunert S et al. |
Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion
Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28
PDF Summary Figures
Figure |
|
|
Magnesium - intrakoronar - intravenös
Figure 1: Experimental preparation and protocol of intracoronary magnesium (A) and intravenous magnesium (B) (time in min)
Keywords: Graphische Darstellung,
heart,
Herz,
magnesium,
magnesium,
myocardium,
Myokard,
protocol,
Protokoll
|
|
|
|
Magnesium - Kalium - Serumkonzentration
Figure 2: Total serum concentration of magnesium and potassium during intravenous infusion of magnesium potassium aspartate or placebo. Occl. = time period of left anterior descending artery
occlusion; Reperfusion = time period of reperfusion of the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or placebo was infused intravenously;
values are means +/- SD
Keywords: Aspartate,
Concentration,
Diagramm,
Infusion,
Infusion,
Kalium,
Kaliumaspartat,
Konzentration,
magnesium,
magnesium,
Magnesiumaspartat,
potassium,
Serum,
Serum
|
|
|
|
Magnesium - Linksventrikulärer Druck
Figure 3: Left ventricular pressure (LVP) during intracoronary magnesium aspartate use (A-upper panel) and intravenous magnesium potassium aspartate use (B-lower panel). Occl. = time period of left anterior descending artery occlusion; Reperfusion =
time period of left anterior descending artery reperfusion; Mg i.c. = time period when magnesium aspartate or vehicle was infused into
the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means +/- SD
Keywords: Aspartate,
Diagramm,
Druck,
Infusion,
Infusion,
magnesium,
magnesium,
Magnesiumaspartat,
pressure,
ventricle,
Ventrikel
|
|
|
|
Magnesium-Kalium-Aspartat - Herzfrequenz
Figure 4: Heart rate during administration of intravenous magnesium potassium aspartate in ischaemia-reperfusion. HR = heart rate; Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of reperfusion of the left
anterior descending artery; Infusion i.v., time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means +/- SD; Mg2+-K+ vs Control; P < 0.001
Keywords: Aspartate,
Diagramm,
heart rate,
Herzfrequenz,
Kalium,
Kaliumaspartat,
magnesium,
magnesium,
Magnesiumaspartat,
potassium
|
|
|
|
Magnesium - Linksventrikulärer Druck
Figure 5A-B: A: Left ventricular pressure (LVP) during intravenous infusion of magnesium potassium aspartate or placebo. B: Regional wall function in the anterior (ischaemic) and posterior (non-ischaemic) wall during intracoronary infusion of
magnesium aspartate or vehicle (A-upper panel) and intravenous infusion of magnesium potassium aspartate or vehicle (B-lower panel). WThSYS = systolic wall thickening; Occl. = time period of left anterior descending coronary artery occlusion; Reperfusion = time period of left anterior descending artery reperfusion; Mg i.c. = time period when magnesium aspartate or vehicle was infused into the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means ± SD
Keywords: Aspartate,
Diagramm,
Druck,
Infusion,
Infusion,
Kalium,
Kaliumaspartat,
magnesium,
magnesium,
Magnesiumaspartat,
potassium,
pressure,
ventricle,
Ventrikel,
wall function,
Wandbewegung
|
|
|
|
Magnesium - Infarktgröße
Figure 6: Infarct size as percentage of area at risk after intracoronary magnesium aspartate or placebo and intravenous magnesium potassium aspartate or placebo; values are single values and means +/- SD (filled symbols)
Keywords: Aspartate,
infarct size,
Infarktgröße,
magnesium,
magnesium,
Magnesiumaspartat,
myocardial infarction,
Myokardinfarkt
|
|
|
|
|